urothelial cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
urothelial cancer
Jul 10, 2024, 06:36 |
Insight
Paolo Tarantino: Intersecting data with the MAT2A inhibitor IDE397 in MTAPdel lung and urothelial cancer
Paolo Tarantino shared a post by Bio Stocks on X, adding: . "Intersecting data with…
Jul 2, 2024, 13:03 |
Insight
Maciej M Mrugala: Updates in advanced urothelial carcinoma at the Mayo Clinic and University of Athens meeting
Petros Grivas shared a post by Maciej M Mrugala, Director-Neuro-Oncology Fellowship Program at Mayo Clinic on…
Jul 1, 2024, 14:48 |
Blog
Daniel Castellano: Great proposals in a urothelial cancer workshop at GUARD Symposium 2024
Daniel Castellano, Medical Oncologist at University Hospital October 12, shared on X: “Great discussion and…
Jun 25, 2024, 04:23 |
Insight
Post ASCO24 update on urothelial cancer by Benjamin Garmezy
Cathy Eng shared on X: "Benjamin Garmezy providing urothelial cancer with updated PRO data re:…
Jun 11, 2024, 15:03 |
Blog
Shilpa Gupta: I was honored to present PROs from the pivotal EV-302 trial at ASCO24
Shilpa Gupta shared a post on LinkedIn: "On behalf of the entire EV 302 team, I…
Jun 6, 2024, 06:52 |
Insight
Sabine D. Brookman-May: Excellent coverage on lymph-node-only metastatic urothelial cancer
Sabine D. Brookman-May, Professor of Urology at Munchen University, shared a post by UroToday.com on X,…
Jun 4, 2024, 14:59 |
Societies
15 Posts From ASCO24 Day 4 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
Jun 4, 2024, 10:19 |
Insight
Earle Burgess: The big news in advanced urothelial (bladder) cancer at ASCO24 isn’t at ASCO24
Earle Burgess, Genitourinary Medical Oncologist, Atrium Health Levine Cancer Institute, shared a post on LinkedIn: “The…
Jun 3, 2024, 11:57 |
Societies
Tanja Obradovic: Very dynamic day at ASCO2024
Tanja Obradovic shared a post on LinkedIn: "Very dynamic ASCO2024 day as we learned quite…
May 26, 2024, 08:41 |
Blog
We are pleased to present new data at ASCO24 - Natera Oncology
Natera Oncology shared a post on X: “We are pleased to present new data at…
May 20, 2024, 11:35 |
Insight
Giuseppe Banna: Join us for an update on the latest news from ASCO24
Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared on LinkedIn: “Join…
May 19, 2024, 10:12 |
Insight
Erman Akkus: Is oncologic treatment of very advanced disease associated with improved survival?
Erman Akkus, Medical Oncology Fellow at Ankara University shared a post on X: “Is oncologic treatment…
May 14, 2024, 09:21 |
Drugs
Piotr Wysocki: Pembrolizumab prevents recurrence in BCG-resistant bladder cancer
Piotr Wysocki recently posted on LinkedIn: "Necchi A et al. published a phase II single-arm study…
May 8, 2024, 07:02 |
Insight
Piotr Wysocki: Immunotherapy after chemotherapy may be the right choice
Piotr Wysocki recently shared on LinkedIn: "Mariniello A. et al. published results of an important preclinical…
May 2, 2024, 15:20 |
Blog
Paolo Tarantino: Impressive to think at the journey of ADCs over the last five years
Paolo Tarantino shared on LinkedIn: "Impressive to think at the journey of ADCs over the last…
Apr 26, 2024, 17:55 |
Insight
Piotr Wysocki: NECTIN4 amplification is a predictive factor for enfortumab vedotin efficacy
Piotr Wysocki recently shared on LinkedIn: "Kluemper et al. published results of a study evaluating NECTIN4…
Apr 16, 2024, 12:22 |
Blog
Shilpa Gupta: Amazing to see our first patient enrolled on EV-302 still in complete remission after 3 years
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared on LinkedIn: "Amazing to see…
Apr 8, 2024, 22:27 |
Insight
Adjuvant Therapy for Urothelial Cancer in Advances in Oncology - New Paper Alert!
Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future Directions Authors: Charbel Hobeika,…
Apr 8, 2024, 15:36 |
Insight
Shilpa Gupta: Happy to share our comprehensive review on adjuvant treatment of muscle-invasive urothelial cancer
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared on LinkedIn: "Happy to share…
Mar 15, 2024, 15:26 |
Insight
Enfortumab+pembrolizumab combination as the 1st line treatment of choice for advanced urothelial cancer - summary by Piotr J. Wysocki
Piotr J. Wysocki, Professor of Medicine, Head of Department of Oncology at Jagiellonian University Hospital,…
Mar 12, 2024, 00:16 |
Blog
The Oscar goes to EV-pembro in metastatic bladder cancer! - Tumor Board Tuesday
Tumor Board Tuesday published the following post on X: "The Oscar goes to EV-pembro in…
Mar 7, 2024, 17:22 |
Insight
Mohammad Jad Moussa: The new EVP 'fissure' challenges the dichotomy of cisplatin/platinum fitness
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared on…
Feb 16, 2024, 17:48 |
Blog
Mohammad Jad Moussa: "La Crème de La Crème" panel discussing wealthy outcomes from the UNITE study
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, recently shared…
Feb 1, 2024, 17:24 |
Drugs
Day 2 of GU24 ASCO Highlights by Oncology Brothers
Oncology Brothers shared on their X/Twitter: "Day 2 of GU24 ASCO Highlights 1. UNITE: EV…
Jan 20, 2024, 17:47 |
Blog
Roberto Iacovelli: Wonderful presentation from my friend Enrique Grande
Roberto Iacovelli, Associate Profesor of Medical Oncology at Catholic University, Comprehensive Cancer Center of Rome,…
Dec 8, 2023, 17:46 |
Drugs
Earle Burgess: Interested in new treatments being developed for advanced (urothelial) bladder cancer?
Earle Burgess, Chief of the Genitourinary Oncology Section at Atrium Health, Levine Cancer Institute, shared…
Jun 28, 2023, 17:38 |
Positive
ADCs keep showing impressive activity across cancers - Paolo Tarantino
ADCs keep showing impressive activity across cancers. 1L EV+pembro led to 64% ORR among patients…
All:
27
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube